
Top insights from the Endpoints at ASCO McKesson leadership panel
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportMcKesson and Health Mart pharmacies support the well-being of communities and offer seasonal vaccinations.
Read Time: 3 minutes
As the days begin to grow shorter and temperatures get colder, health officials are gearing up for what could be an unprecedented season of viral illnesses. With an increase in influenza and COVID-19 cases, public health agencies are urging individuals to stay vigilant and take advantage of available preventive measures.
But there’s another virus that has long wreaked havoc on healthcare systems in tandem with the seasonal flu: Respiratory Syncytial Virus, commonly known as RSV.
Historically, RSV has been considered a common illness in children, but it can pose serious health risks to older adults, leading to severe respiratory infections.
Here’s the good news: In a significant development, the Centers for Disease Control and Prevention (CDC) now recommends that adults ages 60 years and older can receive an RSV vaccine if eligible and deemed appropriate by a healthcare provider. Introducing RSV vaccines for this age group marks a significant step forward in preventing RSV-related complications and hospitalizations.
As one of the largest distributors of seasonal flu vaccines in the U.S., McKesson is supporting the distribution and administration of immunizations targeting many of these viruses, including the seasonal flu, RSV and the new COVID-19 vaccines that have been updated for the 2023-2024 season.
And Health Mart pharmacies – a franchise network of independently owned and operated pharmacies supported by McKesson – may serve as a destination for many to receive these vaccines as they become available in community pharmacies across the U.S.
“Independent pharmacies that are a part of Health Mart, play an important role in maintaining their community’s health,” said Nancy Lyons, BSPharm, MBA, CDCES, chief pharmacy officer, Health Mart. “As one of the most accessible and trusted healthcare providers, pharmacists are well equipped to educate their communities this season and year-round on how to protect themselves against numerous viruses. It’s important for individuals to know the risks and benefits of all vaccines. That’s why Health Mart pharmacists take time to educate their patients and provide personalized care.”
Supporting the Commercialization of COVID-19 Vaccines
McKesson is uniquely positioned to accommodate the receiving, storage and distribution of all three new single-strain commercial vaccines offered by Pfizer, Moderna and Novavax for the 2023-2024 season. It’s a role the company has played since 2020 as the U.S. government’s exclusive centralized distributor for frozen and refrigerated COVID-19 vaccines.
“In a commercialized model, the COVID-19 vaccines will be available for direct purchase through the wholesale distributors and shipped to pharmacies and providers across the United States, similar to how flu vaccines are distributed,” says Ammie McAsey, senior vice president, Customer Distribution Experience, McKesson U.S. Pharmaceutical.
Through our U.S. Pharmaceutical and Medical-Surgical business segments, McKesson is equipped to centrally store the vaccines at the proper temperatures, ultra-frozen, frozen or refrigerated, and is working with Pfizer, Moderna and Novavax to help handle customer demand.
Protecting Yourself and Your Loved Ones
As the nation looks ahead to this fall and winter season, the convergence of new COVID-19 vaccines, seasonal flu shots and RSV vaccines for older adults serves as a reminder of the importance of protecting the well-being of yourself and others.
The CDC recommends:
Consult with your pharmacist or healthcare provider to determine what’s best for yourself and your family.
“Getting vaccinated against these respiratory viruses is key to reducing the risk of spreading them to loved ones and others, especially as we gather together during the holidays,” says Lyons. “More importantly, if you feel sick, avoid close contact with others to avoid the possible spread of any of the viruses. With collective efforts, we can contribute to a healthier and safer season for all.”
Top insights from the Endpoints at ASCO McKesson leadership panel
Insights and Takeaways for The Next Chapter in Specialty Medicine from Asembia AXS25
Enhancing patient access and engagement in clinical trials.
Learn how InspiroGene is helping deliver revolutionary cell and gene therapies to patients in need.
Insights from the 2025 CoverMyMeds Medication Access Report, From Barriers to Bridges
For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.
Learn more about RxOwnership, McKesson’s strategic consultants who help independent pharmacy owners navigate challenges, optimize operations and achieve financial health.
During the recent STAT @ ASH event in San Diego, panelists explored the role of community oncology in advancing precision medicine for cancer care.
Learn about McKesson’s new Cell and Gene Therapy (CGT) brand, InspiroGene, and the launch of a first-of-its-kind report about the CGT landscape and its future trajectory.
Milken Institute Future of Health Summit panelists address critical industry challenges and explore ways to futureproof the pharmaceutical supply chain.